Demand for GLP-1 medication for weight loss is rising rapidly in Europe – especially in the United Kingdom, Germany and France. The development shows that obesity medication is becoming a global phenomenon and that discussion about long-term health is relevant across the global community. Although medicine can lead to impressive weight loss in the short term, the long-term health consequences are often overlooked. Research indicates that this is the best path to lasting weight loss and improved health for most people. Long-term, healthy weight loss from a global perspectiveFor us as a global community, the ambition should be to offer safe and accessible alternatives that support long-term and healthy weight loss.